[1] CHEN P J,FURUSE J,HAN K H,et al. Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinion[J]. Liver Int,2010,30(10): 1427-1438. [2]雷永红, 吕文平, 王海.肝细胞癌患者血清miR-221和miRNA-122的检测及其临床意义[J].河北医科大学学报,2013,34(5):522-525. [3]吴瑞珊, 温旺荣.外周血miRNA的诊断意义[J].分子诊断与治疗杂志,2012,4(2):131-136. [4] LIU W H, CHEN C H,YEH K H,et al.ADAR2-meded editing of miR-214iat and miR-122 precursor and antisense RNA transcripts in liver cancers[J]. PLoS One,2013,8(12): e81922. [5]XING T J,XU H T, YU W Q,et al. Methylation regulation of liver-specific microRNA-122 expression and its effects on the proliferation and apoptosis of hepatocellular carcinoma cells[J].Genet Mol Res,2013,12(3): 3588-3597 .